Top compounds associated with response to APOLD1


Feature Type Standardized
Nominal ANOVA
mRNA ML312 CTRPv2 pan-cancer AAC 0.18 0.02
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.02
mRNA THZ-2-49 GDSC1000 pan-cancer AAC 0.069 0.02
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.083 0.02
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.02
mRNA CH5424802 GDSC1000 pan-cancer AAC 0.079 0.02
mRNA lapatinib GDSC1000 pan-cancer AAC -0.11 0.02
mRNA B02 CTRPv2 pan-cancer AAC -0.089 0.02
mRNA ZM-447439 GDSC1000 pan-cancer AAC -0.084 0.02
mRNA Vandetanib CCLE pan-cancer AAC -0.11 0.02
Download CSV